e-learning
resources
Paris 2018
Monday, 17.09.2018
Pulmonary tuberculosis: long term complications, rehabilitation and challenges
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Use of pleural fluid interferon-gamma enzyme-linked immunospot (ELISPOT) assay in the evaluation of undiagnosed pleural effusion
Z. Hashim (Lucknow, India), A. Nath (Lucknow, India), V. Agarwal (Lucknow, India), R. Mishra (Lucknow, India)
Source:
International Congress 2018 – Pulmonary tuberculosis: long term complications, rehabilitation and challenges
Session:
Pulmonary tuberculosis: long term complications, rehabilitation and challenges
Session type:
Thematic Poster
Number:
2760
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Z. Hashim (Lucknow, India), A. Nath (Lucknow, India), V. Agarwal (Lucknow, India), R. Mishra (Lucknow, India). Use of pleural fluid interferon-gamma enzyme-linked immunospot (ELISPOT) assay in the evaluation of undiagnosed pleural effusion. 2760
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Related content which might interest you:
Rapid diagnosis of pulmonary TB by BAL enzyme-linked immunospot assay in an immunocompromised host
Source: Eur Respir J 2008; 31: 1132-1135
Year: 2008
Local immunodiagnosis of pulmonary tuberculosis by enzyme-linked immunospot
Source: Eur Respir J 2008; 31: 261-265
Year: 2008
Usefulness of whole blood interferon-γ assay and interferon-γ enzyme-linked immunospot assay for the diagnosis of active tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 139s
Year: 2006
Rapid diagnosis of pulmonary tuberculosis by an enzyme-linked immunospot assay using induced sputum cells
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013
Using a whole-blood interferon-gamma assay to improve diagnosis of tuberculous pleural effusion
Source: Eur Respir J 2010; 36: 679-681
Year: 2010
Performance of a commercial whole blood interferon-gamma release assays in the management of pleural effusions
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009
Clinical utility of pleural fluid interferon-gamma release assay in tuberculous pleurisy diagnosis
Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections
Year: 2017
Diagnostic value of quantitative measurement of pleural fluid interferon-gamma (IFN–gamma) versus QuantiFERON-TB Gold in tube assays (QFT-IT) in blood, pleural fluid and isolated pleural fluid cells in tuberculous pleural effusion
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013
Interferon gamma in pleural fluid for diagnosing tuberculosis. A comparison between 2 techniques: RIA and ELISA
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009
Usefulness of the interferon-γ enzyme-linked immunospot assay for the diagnosis of active and latent tuberculosis in immunocompetant and chronic renal failure patients
Source: Annual Congress 2009 - Tuberculosis contact screening
Year: 2009
Comparison of diagnostic utility of pleural fluid ADA and interferon-gamma release assay (IGRA) in differentiating tubercular and non-tubercular exudative pleural effusion
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015
Development of an enzyme-linked immunosorbent assay for the detection of human calretinin in plasma and serum of mesothelioma patients
Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology
Year: 2010
The clinical utility of interferon-γ release assay (IGRA) from pleural fluid in addition to IGRA from blood in patients with pleural effusion
Source: Annual Congress 2010 - Extrapulmonary tuberculosis
Year: 2010
Multiple serodiagnosis of nontuberculous mycobacterial infections by enzyme-linked immunosorbent assay
Source: Eur Respir J 2007; 30: Suppl. 51, 664s
Year: 2007
Th17 clones in BOS evaluated by enzyme linked immunospot assay
Source: Annual Congress 2012 - Novel approaches to lung transplantation
Year: 2012
Negative effect of ferritin levels on T-SPOT.TB, an enzyme-linked immunospot based interferon-gamma release assay using Mycobacterium tuberculosis specific antigens, in the smear-positive active pulmonary tuberculosis.
Source: International Congress 2018 – Diagnosis of tuberculosis
Year: 2018
Rapid diagnosis of smear-negative tuberculosis by bronchoalveolar-lavage enzyme-linkend immunospot: interim analysis of a TBNET study
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease
Year: 2007
Cytokine profile in lung cancer microenvironment- analysis of bronchoalveolar lavage fluid by Luminex assay
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017
Diagnostic performance of antigen induced IFN-? production in pleural fluid in tuberculous pleurisy
Source: International Congress 2019 – Tuberculosis: diagnosis
Year: 2019
Mast cell tryptase concentration measured with B12 antibody-based immunoassay in bronchoalveolar lavage fluid from patients with interstitial lung disease
Source: Eur Respir J 2004; 24: Suppl. 48, 10s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept